Literature DB >> 7787713

Dynamic contrast-enhanced MR imaging of fibrolamellar hepatocellular carcinoma.

K Corrigan1, R C Semelka.   

Abstract

The magnetic resonance (MR) appearance of fibrolamellar hepatocellular carcinoma (FL-HCC) on T1- and T2-weighted and dynamic serial postgadolinium-DTPA images is reported. Both tumors were large (> 7 cm in shortest dimension) and had central regions of low signal intensity on T1- and T2-weighted images. Diffuse heterogeneous enhancement of the tumors occurred on immediate postcontrast images. Lesions became more homogeneous in enhancement over time, but lack of enhancement of central portions of the tumor persisted. Although persistent lack of enhancement of the tumor scar on late postcontrast MR images may be characteristic of FL-HCC compared with delayed enhancement in focal nodular hyperplasia, the potential similarities between these tumors is stressed.

Entities:  

Mesh：

Substances：

Year:  1995        PMID： 7787713     DOI： 10.1007/bf00201518

Source DB:  PubMed          Journal:  Abdom Imaging        ISSN： 0942-8925


  12 in total

1.  Focal liver disease: comparison of dynamic contrast-enhanced CT and T2-weighted fat-suppressed, FLASH, and dynamic gadolinium-enhanced MR imaging at 1.5 T.

Authors:  R C Semelka; J P Shoenut; M A Kroeker; H M Greenberg; F C Simm; G Y Minuk; R M Kroeker; A B Micflikier
Journal:  Radiology       Date:  1992-09       Impact factor: 11.105

2.  Gynecomastia as a presenting sign of fibrolamellar carcinoma of the liver.

Authors:  J J McCloskey; E L Germain-Lee; J A Perman; L P Plotnick; A H Janoski
Journal:  Pediatrics       Date:  1988-09       Impact factor: 7.124

3.  Characteristics of fibrolamellar hepatocellular carcinoma. A study of nine cases and a review of the literature.

Authors:  O Soreide; A Czerniak; H Bradpiece; S Bloom; L Blumgart
Journal:  Am J Surg       Date:  1986-04       Impact factor: 2.565

4.  Differentiation of hepatic hemangiomas from metastases by dynamic contrast-enhanced MR imaging.

Authors:  B Hamm; E Fischer; M Taupitz
Journal:  J Comput Assist Tomogr       Date:  1990 Mar-Apr       Impact factor: 1.826

5.  Focal nodular hyperplasia of the liver: assessment with contrast-enhanced TurboFLASH MR imaging.

Authors:  D Mathieu; A Rahmouni; M C Anglade; B Falise; C Beges; P Gheung; J J Mollet; N Vasile
Journal:  Radiology       Date:  1991-07       Impact factor: 11.105

6.  MR imaging of hepatic focal nodular hyperplasia: characterization and distinction from primary malignant hepatic tumors.

Authors:  G R Mattison; G M Glazer; L E Quint; I R Francis; R L Bree; W D Ensminger
Journal:  AJR Am J Roentgenol       Date:  1987-04       Impact factor: 3.959

7.  Central scars in primary liver tumors: MR features, specificity, and pathologic correlation.

Authors:  E Rummeny; R Weissleder; S Sironi; D D Stark; C C Comptom; P F Hahn; S Saini; J Wittenberg; J T Ferrucci
Journal:  Radiology       Date:  1989-05       Impact factor: 11.105

8.  Fibrolamellar carcinoma of the liver: a tumor of adolescents and young adults with distinctive clinico-pathologic features.

Authors:  J R Craig; R L Peters; H A Edmondson; M Omata
Journal:  Cancer       Date:  1980-07-15       Impact factor: 6.860

9.  Fibrolamellar hepatocellular carcinoma: MR appearance.

Authors:  D S Titelbaum; H Hatabu; M L Schiebler; H Y Kressel; D R Burke; S H Saul
Journal:  J Comput Assist Tomogr       Date:  1988 Jul-Aug       Impact factor: 1.826

10.  Focal nodular hyperplasia of the liver: MR imaging and pathologic correlation in 37 patients.

Authors:  V Vilgrain; J F Fléjou; L Arrivé; J Belghiti; D Najmark; Y Menu; M Zins; M P Vullierme; H Nahum
Journal:  Radiology       Date:  1992-09       Impact factor: 11.105
View more
  7 in total

1.  Fibrolamellar hepatocellular carcinoma with biliary tumor thrombus: an unreported association.

Authors:  Anna Maria De Gaetano; Erida Nure; Ugo Grossi; Francesco Frongillo; Rosellina Russo; Fabio Maria Vecchio; Maria Carmen Lirosi; Gabriele Sganga; Carla Felice; Lorenzo Bonomo; Salvatore Agnes
Journal:  Jpn J Radiol       Date:  2013-07-13       Impact factor: 2.374

Review 2.  Fibrolamellar hepatocellular carcinoma. Case reports and a review of the literature.

Authors:  S Saab; F Yao
Journal:  Dig Dis Sci       Date:  1996-10       Impact factor: 3.199

Review 3.  MRI features of histologic subtypes of hepatocellular carcinoma: correlation with histologic, genetic, and molecular biologic classification.

Authors:  Ja Kyung Yoon; Jin-Young Choi; Hyungjin Rhee; Young Nyun Park
Journal:  Eur Radiol       Date:  2022-03-08       Impact factor: 7.034

Review 4.  Clinical value of MRI liver-specific contrast agents: a tailored examination for a confident non-invasive diagnosis of focal liver lesions.

Authors:  Ahmed Ba-Ssalamah; Martin Uffmann; Sanjai Saini; Nina Bastati; Christian Herold; Wolfgang Schima
Journal:  Eur Radiol       Date:  2008-09-23       Impact factor: 5.315

5.  CT and MRI of primary and metastatic fibrolamellar carcinoma: a case series of 37 patients.

Authors:  R K G Do; A McErlean; C S Ang; R P DeMatteo; G K Abou-Alfa
Journal:  Br J Radiol       Date:  2014-06-04       Impact factor: 3.039

6.  MRI of Focal Liver Lesions.

Authors:  Nils Albiin
Journal:  Curr Med Imaging Rev       Date:  2012-05

7.  Imaging features of fibrolamellar hepatocellular carcinoma in gadoxetic acid-enhanced MRI.

Authors:  Viktoria Palm; Ruofan Sheng; Philipp Mayer; Karl-Heinz Weiss; Christoph Springfeld; Arianeb Mehrabi; Thomas Longerich; Anne Katrin Berger; Hans-Ulrich Kauczor; Tim Frederik Weber
Journal:  Cancer Imaging       Date:  2018-03-01       Impact factor: 3.909
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.